U.S. Entertainment Stock News

NYSE:SPGI
NYSE:SPGICapital Markets

S&P Global Expands AI Energy Insights While Mobility Tracks Used Car Volatility

S&P Global (NYSE:SPGI) has completed the acquisition of Enertel AI Corporation. The deal adds AI driven short term power price forecasting to S&P Global's energy division. The move comes as its Mobility unit continues to track volatility in the used car market. S&P Global, known for its credit ratings, benchmarks, and data intelligence, is leaning further into energy analytics with the Enertel AI acquisition. By folding Enertel's forecasting tools into its energy division, the company is...
NasdaqGS:SNPS
NasdaqGS:SNPSSoftware

Can Synopsys (SNPS) NASA Simulation Work Deepen Its Systems Engineering Edge In Mission-Critical Markets?

NASA previously selected Synopsys, EMA, and Cesium (part of Bentley Systems) to use advanced simulation and digital twin tools to verify Artemis spacesuit safety and lunar communications performance under harsh plasma, regolith, and terrain conditions. This work highlights Synopsys’ role in mission-critical engineering for aerospace, extending its silicon-to-systems capabilities into high-stakes government applications such as lunar EVA and connectivity planning. Next, we’ll examine how...
NYSE:LC
NYSE:LCConsumer Finance

Assessing LendingClub (LC) Valuation As Insider Selling And Profit Concerns Prompt Investor Caution

Event overview: why LendingClub is drawing attention now LendingClub (LC) is back in focus after recent analysis flagged the shares as trading above intrinsic value, alongside insider sales over the past 3 months and questions around profitability and long term growth. See our latest analysis for LendingClub. LendingClub’s share price has recently moved to US$15.85, with a 1 month share price return of 14.86% and a 1 year total shareholder return of 67.72%. However, the 3 month share price...
NasdaqGS:AGIO
NasdaqGS:AGIOBiotechs

A Look At Agios Pharmaceuticals (AGIO) Valuation As PYRUKYND Growth Prospects Face Mixed Signals

Agios Pharmaceuticals (AGIO) focuses on treatments for rare blood disorders, with lead product PYRUKYND targeting pyruvate kinase deficiency and sickle cell disease. This provides a starting point for assessing how current revenue and losses relate to its market value. See our latest analysis for Agios Pharmaceuticals. Recent momentum has been mixed, with the share price at $33.30 after a 19.57% 1 month share price return and a 15.91% 3 month share price return, while the 1 year total...
NasdaqGS:NTRA
NasdaqGS:NTRABiotechs

Is It Time To Reassess Natera (NTRA) After Its Mixed Share Price Performance?

If you are wondering whether Natera's current share price reflects its true worth, this article walks through the key numbers that matter before you commit fresh capital. Over the last week the stock returned 2.6%, over the last month 14.3%, while year to date it is down 6.2% and the 1 year return sits at 41.5%. This gives a mixed picture of momentum and risk sentiment around the current US$214.64 share price. Recent coverage has focused on Natera's position in diagnostics and its progress...
NYSE:UNP
NYSE:UNPTransportation

Assessing Union Pacific’s (UNP) Valuation As Recent Share Price Momentum Draws Fresh Attention

How Union Pacific’s Recent Performance Frames the Investment Debate Union Pacific (UNP) has drawn fresh attention as its shares recently changed hands at around $252, with returns over the past month and past 3 months outpacing its year to date move. That backdrop, alongside a value score of 5 and an indicated intrinsic discount of about 21%, is prompting investors to reassess how the railroad’s current price reflects its earnings profile and business mix. See our latest analysis for Union...
NYSE:BORR
NYSE:BORREnergy Services

Is It Too Late To Consider Borr Drilling (NYSE:BORR) After Its 203% One Year Rally?

For investors considering whether Borr Drilling at around US$5.70 offers further upside or if expectations are already reflected in the price, a useful starting point is understanding what the current market price implies about value. The stock has seen mixed recent returns, with about a 4.5% decline over the last 7 days, a 12.6% gain over 30 days, and a 42.9% gain year to date. The 1 year return of 203.2% contrasts with a 3 year return reflecting a 19.1% decline and a 5 year return of...
NasdaqGM:VCYT
NasdaqGM:VCYTBiotechs

Assessing Veracyte (VCYT) Valuation After A Recent Share Price Rebound

Recent share performance and business snapshot Without a clear news catalyst, Veracyte (VCYT) has still caught investor attention after a recent move in the share price. This has prompted a closer look at its diagnostics-focused business and current return profile. The company reports US$517.145 million in revenue from diagnostic products and biopharmaceutical services, with US$496.598 million generated in the United States and US$20.547 million from international markets. Recent shareholder...
NasdaqGS:NVCR
NasdaqGS:NVCRMedical Equipment

Is NovoCure’s (NVCR) Leadership Consolidation Clarifying Its Innovation Strategy Or Complicating Governance Signals?

NovoCure recently expanded Uri Weinberg, M.D., Ph.D.’s responsibilities by appointing him Chief Medical Officer in addition to Chief Innovation Officer, with a CHF 5,000 monthly stipend increase tied to the added role while other employment terms remain unchanged. At the same time, insider share sales of about US$2.3 million, ongoing Tumor Treating Fields clinical programs, and leadership consolidation are shaping how investors view NovoCure’s execution and governance approach. We’ll now...
NYSE:UE
NYSE:UERetail REITs

A Look At Urban Edge Properties (UE) Valuation After Recent Share Price Momentum

Why Urban Edge Properties Is Back On Investor Radars Urban Edge Properties (UE) has quietly attracted fresh attention as its shares have moved higher over the past month and past 3 months, prompting investors to reassess this retail focused real estate investment trust. See our latest analysis for Urban Edge Properties. With the share price at $21.24, Urban Edge Properties has seen solid short term momentum, including a 14.19% 90 day share price return. Longer term total shareholder returns...
NYSE:DGX
NYSE:DGXHealthcare

Quest Diagnostics Expands Drug Screening Services As Investors Weigh Growth Story

Quest Diagnostics is expanding its drug screening capabilities to meet tighter global testing regulations. The company is rolling out oral fluid and fingerprint-based workplace testing as part of a broader service-focused offering. This shift targets growth opportunities in the global drug screening market beyond routine diagnostics. Quest Diagnostics, NYSE:DGX, is leaning into drug screening as regulators worldwide push for more rigorous and flexible testing options. With a current share...
NYSE:GLW
NYSE:GLWElectronic

Assessing Corning’s (GLW) Valuation After AI Data Center Demand And Meta Fiber Expansion Deals

Corning (GLW) is back in focus after a series of developments tied to AI infrastructure, including the expansion of its optical cable capacity with Meta Platforms and increased attention on its Optical Communications business. See our latest analysis for Corning. The recent AI infrastructure headlines come on top of a powerful run, with Corning’s 30 day share price return of 33.84% and year to date share price return of 90.60%, alongside a very large 1 year total shareholder return that...
NYSE:CCI
NYSE:CCISpecialized REITs

How Crown Castle’s Cautious FFO Outlook and Tower-Only Pivot Could Reframe CCI’s Investment Case

Crown Castle Inc. previously announced it would release its first-quarter 2026 results on Wednesday, April 22, 2026, after the market close, accompanied by a same-day conference call and webcast with supporting materials on its website. Investor attention has increasingly centered on a cautious outlook for funds from operations and the implications of Crown Castle’s transition to a pure-play tower model, which has raised questions about its organic growth profile versus peers and followed on...
NYSE:SSD
NYSE:SSDBuilding

Is Simpson Manufacturing (SSD) Fairly Priced After Its Multi Year Share Price Run?

If you are wondering whether Simpson Manufacturing is priced fairly or if the shares are getting ahead of themselves, the current setup makes valuation the key question. The stock last closed at US$177.89, with returns of 6.8% over 7 days, 8.0% year to date, 19.4% over 1 year, 63.9% over 3 years, and 76.6% over 5 years that many investors will want to put into context. Recent coverage of the company has focused on its position in the capital goods space and how investors are reassessing...
NYSE:GNK
NYSE:GNKShipping

Genco Faces Intensified Control Contest As Diana Pushes Cash Offer

Diana Shipping has launched a contested board nomination and all cash takeover bid for Genco Shipping & Trading (NYSE:GNK). Genco's board has rejected Diana's acquisition offer as inadequate, while Diana seeks to replace the current board with its own independent nominees. Both companies are sending direct communications to shareholders, trading public accusations over entrenchment, governance, and potential value outcomes. Genco operates in the dry bulk shipping sector, transporting...
NYSE:J
NYSE:JProfessional Services

Is Jacobs Solutions (J) Share Price Pullback Creating A Potential Opportunity Now

If you are wondering whether Jacobs Solutions at around US$125 a share still offers value, the answer depends on how you think about what the business is worth versus what the market is currently willing to pay. The stock has seen mixed returns, with a 1.4% decline over the last 7 days and a 2.1% decline over the past month, yet it has delivered 8.9% over 1 year and 34.9% over 3 years, while year to date it is down 7.3%. Recent coverage has focused on Jacobs Solutions as a major player in...
NYSE:CRM
NYSE:CRMSoftware

Is It Time To Reconsider Salesforce (CRM) After Its Recent Share Price Slump?

Wondering whether Salesforce at around US$171 per share is starting to look interesting again, or if the stock still carries too much downside risk for your portfolio. The share price has been under pressure recently, with returns of a 6.4% decline over 7 days, an 11.2% decline over 30 days, a 32.5% decline year to date, and a 32.3% decline over the last year, which can change how the market views both its potential and its risks. These moves sit against a backdrop where Salesforce continues...
NasdaqGS:CMCSA
NasdaqGS:CMCSATelecom

Comcast Builds AI Ad Tools And Faster Broadband As Shares Lag Targets

Comcast subsidiary FreeWheel has launched Context Engine, an AI-powered contextual ad targeting tool for premium video. The new product is designed to improve ad relevance, monetization, and brand safety for media owners and marketers. Comcast is also expanding its multi-gig internet network to thousands more homes and businesses in Wilton, Connecticut. These moves come as Comcast, NasdaqGS:CMCSA, trades at $28.14 with a value score of 5. For investors watching Comcast, NasdaqGS:CMCSA, the...
NasdaqGS:TER
NasdaqGS:TERSemiconductor

Is It Too Late To Consider Teradyne (TER) After A 395% One Year Surge?

For investors wondering whether Teradyne at around US$365 a share still offers value or if most of the opportunity is already priced in, this article walks through what the numbers indicate about the stock. The share price has been volatile, with returns of 14.1% over the last week, 27.6% over the last month, 76.1% year to date, and 395.4% over the past year. This context can change how you think about both upside and risk. Recent attention on Teradyne has focused on its role within the...
NYSE:EPR
NYSE:EPRSpecialized REITs

EPR Properties (EPR) Expands Six Flags Park Portfolio: What Does This Mean For Experiential Risk?

In early April 2026, EPR Properties closed on six U.S. regional theme parks as part of its previously announced US$315 million acquisition of a seven-park portfolio from Six Flags, with the remaining La Ronde property in Montreal expected to close in the second quarter of 2026 under separate operating arrangements. This expansion deepens EPR’s focus on experiential real estate by adding large-scale attractions under long-term master leases, which are designed to support predictable rental...
NYSE:SOLV
NYSE:SOLVMedical Equipment

Assessing Solventum (SOLV) Valuation After Mixed Quarterly Results And A Sharp Market Reaction

Solventum (SOLV) has been in focus after its latest quarterly report, where revenue came in 1.9% above analyst expectations but earnings per share fell short, prompting a sharp negative reaction in the stock. See our latest analysis for Solventum. Since the earnings release, the 1 day share price return of 2.39% and 7 day return of 10.45% to US$69.02 have only partially offset a 90 day share price return of negative 13.78%. The 1 year total shareholder return of 4.69% points to relatively...
NYSE:NATL
NYSE:NATLDiversified Financial

How NCR Atleos’ Founders Federal ATMaaS Deal Could Shape NATL’s Self-Service Banking Narrative

On 14 April 2026, NCR Atleos Corporation announced that Founders Federal Credit Union will adopt its ATM as a Service model to streamline ATM operations, bolster security, and improve uptime for members across the Carolinas. This agreement highlights how NCR Atleos is embedding itself more deeply in clients' day‑to‑day infrastructure by operating and securing self-service cash access on their behalf. Next, we will examine how this expanded ATMaaS role with Founders Federal Credit Union...
NasdaqGS:TEM
NasdaqGS:TEMLife Sciences

Tempus AI Deepens Oncology Role With Automated Updates And AACR 2026 Data

Tempus AI (NasdaqGS:TEM) has launched an automated clinical update service tied to its AI-enabled clinician portal for ongoing cancer therapy monitoring. The new service is designed to keep treatment recommendations aligned with current guidelines and emerging options without requiring new patient samples. Tempus AI reports 31 research abstracts accepted for presentation at AACR 2026, including an oral presentation and a featured session on AI-powered lab technologies. Tempus AI operates at...
NYSE:GNRC
NYSE:GNRCElectrical

Generac Holdings (GNRC) Is Up 10.9% After New CPower Distributed Generation Alliance - Has The Bull Case Changed?

In early April 2026, CPower Energy announced a collaboration with Generac Holdings to deploy distributed generation solutions across PJM, combining Generac’s equipment and dealer network with CPower’s market access and demand response expertise to support commercial and industrial customers’ resiliency needs. This alliance broadens Generac’s role in distributed energy resources by enabling customers to use generators, storage, and microgrids to earn recurring energy revenues and savings from...